Ching H. Chang

550 total citations
19 papers, 458 citations indexed

About

Ching H. Chang is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ching H. Chang has authored 19 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ching H. Chang's work include Peroxisome Proliferator-Activated Receptors (5 papers), Adipose Tissue and Metabolism (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Ching H. Chang is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (5 papers), Adipose Tissue and Metabolism (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Ching H. Chang collaborates with scholars based in United States, Taiwan and Canada. Ching H. Chang's co-authors include Donald J. Tindall, David R. Rowley, Larry I. Lipshultz, Joel P. Berger, Margaret E. McCann, Harold B. Wood, Peter T. Meinke, Sidney Udenfriend, Thomas J. Lobl and Peter Böhlen and has published in prestigious journals such as Biochemistry, Analytical Biochemistry and Endocrinology.

In The Last Decade

Ching H. Chang

19 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching H. Chang United States 15 195 97 74 58 43 19 458
Manik Ganguly United States 12 150 0.8× 118 1.2× 76 1.0× 71 1.2× 16 0.4× 16 456
Yoshio Morikawa Japan 14 201 1.0× 58 0.6× 32 0.4× 25 0.4× 47 1.1× 65 553
Minoru Ota Japan 13 312 1.6× 119 1.2× 113 1.5× 16 0.3× 45 1.0× 53 601
Lillian J. Wyngarden United States 13 214 1.1× 43 0.4× 178 2.4× 85 1.5× 12 0.3× 15 726
R.J. Warren United Kingdom 9 161 0.8× 52 0.5× 45 0.6× 31 0.5× 31 0.7× 14 362
René Got France 11 242 1.2× 28 0.3× 21 0.3× 11 0.2× 34 0.8× 56 393
Shuai Yu China 13 245 1.3× 17 0.2× 109 1.5× 54 0.9× 26 0.6× 38 461
Thomas P. Whitehead United Kingdom 7 293 1.5× 19 0.2× 26 0.4× 10 0.2× 16 0.4× 14 480
Toshiho Nishita Japan 13 381 2.0× 19 0.2× 21 0.3× 18 0.3× 31 0.7× 61 523
Jeanne M. Rhea United States 14 279 1.4× 74 0.8× 80 1.1× 7 0.1× 31 0.7× 20 588

Countries citing papers authored by Ching H. Chang

Since Specialization
Citations

This map shows the geographic impact of Ching H. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching H. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching H. Chang more than expected).

Fields of papers citing papers by Ching H. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching H. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching H. Chang. The network helps show where Ching H. Chang may publish in the future.

Co-authorship network of co-authors of Ching H. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ching H. Chang. A scholar is included among the top collaborators of Ching H. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching H. Chang. Ching H. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Akiyama, Taro E., Lesley A. McNamara, Neelam Sharma, et al.. (2019). Endothelial Cell–Targeted Deletion of PPARγ Blocks Rosiglitazone-Induced Plasma Volume Expansion and Vascular Remodeling in Adipose Tissue. Journal of Pharmacology and Experimental Therapeutics. 368(3). 514–523. 2 indexed citations
2.
Chang, Ching H., et al.. (2013). Numerical simulation of oxygen transport during the Czochralski silicon crystal growth with a cusp magnetic field. Journal of Crystal Growth. 401. 888–894. 21 indexed citations
3.
Liu, Weiguo, Kun Liu, Harold B. Wood, et al.. (2011). Benzimidazolones: A New Class of Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators. Journal of Medicinal Chemistry. 54(24). 8541–8554. 48 indexed citations
4.
Chen, Xun, Charlotte Burton, Xuelei S. Song, et al.. (2009). An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration. International Journal of Biological Sciences. 5(5). 489–499. 25 indexed citations
5.
Liu, Weiguo, Kun Liu, Harold B. Wood, et al.. (2009). Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia. Journal of Medicinal Chemistry. 52(14). 4443–4453. 18 indexed citations
7.
Chang, Ching H., Lesley A. McNamara, Margaret Wu, et al.. (2008). A novel selective peroxisome proliferator-activator receptor-γ modulator—SPPARγM5 improves insulin sensitivity with diminished adverse cardiovascular effects. European Journal of Pharmacology. 584(1). 192–201. 25 indexed citations
8.
Tindall, Donald J., et al.. (1985). Structure and Biochemistry of the Sertoli Cell. International review of cytology. 94. 127–149. 54 indexed citations
9.
Chang, Ching H., Thomas J. Lobl, David R. Rowley, & Donald J. Tindall. (1984). Affinity labeling of the androgen receptor in rat prostate cytosol with 17.beta.-[(bromoacetyl)oxy]-5.alpha.-androstan-3-one. Biochemistry. 23(11). 2527–2533. 26 indexed citations
10.
Rowley, David R., Ching H. Chang, & Donald J. Tindall. (1984). Effects of Sodium Molybdate on the Androgen Receptor from the R3327 Prostatic Tumor*. Endocrinology. 114(5). 1776–1783. 25 indexed citations
11.
Carroll, Steven L., David R. Rowley, Ching H. Chang, & D. J. Tindall. (1984). Exchange assay for androgen receptors in the presence of molybdate. Journal of Steroid Biochemistry. 21(4). 353–359. 19 indexed citations
12.
Tindall, Donald J., Ching H. Chang, Thomas J. Lobl, & David R. Rowley. (1984). Molecular Properties of the Androgen Receptor in Rat Ventral Prostate a. Annals of the New York Academy of Sciences. 438(1). 39–53. 4 indexed citations
13.
Chang, Ching H. & Donald J. Tindall. (1983). Physicochemical Characterization of the Androgen Receptor in Rat Uterine Cytosol*. Endocrinology. 113(4). 1486–1493. 23 indexed citations
14.
Giménez, T., et al.. (1980). Prolactin and luteinizing hormone (LH) release throughout the postpartum period in the suckled first-calf beef cow. Theriogenology. 14(2). 135–149. 9 indexed citations
15.
Rawlings, N. C., Sean W. Kennedy, Ching H. Chang, James R. Hill, & D. M. Henricks. (1977). Onset of Seasonal Anestrus in the Ewe2. Journal of Animal Science. 44(5). 791–797. 34 indexed citations
16.
Jensen, Leo S., Ching H. Chang, & Kenneth Washburn. (1975). Differential Response in Cardiomyopathy of Chicks and Turkeys to Furazolidone Toxicity. Avian Diseases. 19(3). 596–596. 22 indexed citations
17.
Stein, S, Ching H. Chang, Peter Böhlen, Koubun Imai, & Sidney Udenfriend. (1974). Amino acid analysis with fluorescamine of stained protein bands from polyacrylamide gels. Analytical Biochemistry. 60(1). 272–277. 39 indexed citations
18.
Tarnay, Thomas J., et al.. (1970). Esophageal duplication (foregut cyst) with spinal malformation. Journal of Thoracic and Cardiovascular Surgery. 59(2). 293–298. 16 indexed citations
19.
Chang, Ching H. & Robert M. Carroll. (1967). Roentgenographic barium patterns and gastric secretion. Digestive Diseases and Sciences. 12(6). 614–618. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026